Alector (ALEC) Other Accumulated Expenses (2018 - 2025)
Alector (ALEC) reported Other Accumulated Expenses of $495000.0 for Q4 2025, up 2.7% year-over-year from $482000.0 in Q4 2024, and up 2.7% quarter-over-quarter from $482000.0 in Q4 2024.
Alector (ALEC) Other Accumulated Expenses (2018 - 2025) Analysis & Trends
Alector (ALEC) has 8 years of Other Accumulated Expenses data on file, last reported at $495000.0 in Q4 2025.
- Other Accumulated Expenses for Q4 2025 came in at $495000.0, up 2.7% year-over-year; the trailing twelve-month figure through Dec 2025 was $495000.0 (up 2.7% YoY), and the FY2025 annual result was $495000.0, up 2.7% from the prior year.
- Other Accumulated Expenses improved to $495000.0 in Q4 2025 per ALEC's latest filing, from $482000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $709000.0 in Q4 2022 and troughed at $318000.0 in Q4 2021.
- A 5-year average of $485400.0 and a median of $482000.0 in 2024 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses jumped 122.96% in 2022, then tumbled 40.34% in 2023.
- A 5-year view of Other Accumulated Expenses shows it stood at $318000.0 in 2021, then surged by 122.96% to $709000.0 in 2022, then slumped by 40.34% to $423000.0 in 2023, then rose by 13.95% to $482000.0 in 2024, then advanced by 2.7% to $495000.0 in 2025.
- Business Quant data shows ALEC's Other Accumulated Expenses at $495000.0 in Q4 2025, $482000.0 in Q4 2024, and $423000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 495,000.00 |
| Dec 31, 2024 | 482,000.00 |
| Dec 31, 2023 | 423,000.00 |
| Dec 31, 2022 | 709,000.00 |
| Dec 31, 2021 | 318,000.00 |
| Dec 31, 2020 | 353,000.00 |
| Dec 31, 2019 | 615,000.00 |
| Sep 30, 2019 | 122,000.00 |
| Jun 30, 2019 | 156,000.00 |
| Mar 31, 2019 | 165,000.00 |
| Dec 31, 2018 | 971,000.00 |